Olivia
Online
💸🕵️♂️ Penny Agent 🕵️♂️💸
@pennyagent1
Part-time trader on the search for undiscovered gems, getting in at bottom and holding for big gains. #OTC #NASDAQ #StockTrader #Stocks
Joined January 2022
327 Following
373 Followers
2.3K Posts
$ADIA News out yesterday was well received..closed up 29 percent..
News came out this morning. Adia Nutrition, Inc. Reports Strong Revenue Growth in 2025 Annual Report, Highlighting Transition to Regenerative Medicine and Full SEC Reporting Status
https://t.co/0zDjekwzlg…
$ADIA one of the most overlooked medical company..until now..results tell the story and i love what I am reading..
Definitely worth a look here..
Huge revenue increase for 2025 from $ADIA. Would imagine 2026 will continue to compound this success.
$ADIA showing a sharp pullback after a strong run, now testing a key support zone near the recent lows (~$0.06–$0.08 range). Bounce attempt underway but still below prior consolidation.
Watch:
• Reclaim of $0.14–$0.16 = strength returning
• Failure here = potential retest of lows
Volume spike on selloff suggests caution — not a confirmed reversal yet.
High risk / high reward OTC setup. Manage size accordingly.
$ADIA Company looks to be expanding at a rapid rate as it appears they continue to build a strong business..one of the more intriguing medical companies on the OTC..
#stockstowatch #OTC
$ADHC had been trending cleanly within an ascending channel, but just saw a sharp rejection near the upper trendline.
Now watching:
• $0.0010 area = key support (channel mid/lower)
• Break below = trend structure weakens
• Reclaim of $0.0014–$0.0015 = continuation potential
Volume elevated on the drop — suggests sellers stepped in.
Still an OTC momentum play, but trend is being tested here. Manage risk.
🚀 $ADHC is merging AI & healthcare with GlucoGuard, its flagship diabetes innovation. From a holding co. to a tech-driven health platform—this is the ADHC story: https://t.co/mMd1PsijXS
$ADHC stay tuned, sounds like more to come next week!
$ADIA just posted a major transformation year in its 10-K. Revenue jumped from $6,380 in 2024 to over $700K in 2025, driven by a strategic shift into regenerative medicine.
https://t.co/B4kPK8BgrK
$ADHC
$ADHC - American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA https://t.co/NmL5SsWqO2 via @SeekingAlpha @ADHCMANAGEMENT @MarketCurrents #FDA #News #Updates
$ADHC continuing to move forward with operational updates and business development efforts 👀
Steady progress in the OTC space is key, and the company appears focused on building long-term value.
#OTC #Stocks #Investing
$ADHC accumulating on news. Continuous glucose monitoring from Dexcom will be used to track patient outcomes in real time during the study. #AI #Diabetes #GlucoGuard
🚨 $ADHC just dropped some MAJOR NEWS:
A global CRO is on board for the FDA's final requirement, a sleep safety study, and that's the last thing standing between $ADHC and Breakthrough Device designation in (a space with zero competition) 🤯
$ADHC new high for this year. Watching for break and hold of .0017. Excellent news out today! #AI #Diabetes #GlucoGuard
$ADHC JUST DROPPED MAJOR NEWS TODAY! GlucoGuard (ADHC’s flagship division) has officially retained a top-tier Global Contract Research Organization (CRO) to kick off critical Patient Studies — the next major milestone required for FDA clearance of their groundbreaking nocturnal glucose monitoring & delivery system!
This is the exact step that moves them from development into full clinical validation and commercialization path.
Even better? GlucoGuard already has Level 2 app integration live through $DXCM’s Developer Partner Program, giving it seamless, real-time access to Dexcom’s industry-leading CGM data.
$DXCM = the gold standard in continuous glucose monitoring.
$ADHC = the smart-money play riding that tech straight into the exploding diabetes market.
https://t.co/0ZKcGGFjlA
$ADHC announces GlucoGuard has retained a global CRO to begin FDA-required patient studies focused on safety and efficacy. #GlucoGuard #Diabetes
$ADHC excellent!
Management notes the CRO partnership may also support international expansion efforts, including potential entry into China and India.
$ADHC Love the news just out!
American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA
https://t.co/2m9brw8xlD
Let’s not forget they also have a partnership with $DXCM NASDAQ listed company..
GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program
https://t.co/sRphwyTiAm
$ADHC #News
American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA
https://t.co/qOvp6k52bS
@ADHCMANAGEMENT $ADHC
Stepping stone complete for our flagship design, more news soon
Link to the full release
https://t.co/QFmRSUWj7l
@ADHCMANAGEMENT
$ADHC
Press release approved for tomorrow.
We are also working on a multi week PR rollout to update on what's been happening behind the scenes.
$ADHC off to a strong start this morning. Could get interesting today!
Last Seen Users on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.4M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.1M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.5M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.8M followers
KATY PERRY
@katyperry
87.4M followers
Taylor Swift
@taylorswift13
81.2M followers
Lady Gaga
@ladygaga
72.8M followers
Kim Kardashian
@kimkardashian
69.7M followers
Virat Kohli
@imvkohli
69.5M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.7M followers
The Ellen Show
@theellenshow
62.5M followers
Neymar Jr
@neymarjr
62.2M followers
CNN
@cnn
61.9M followers
X
@x
60.8M followers
Selena Gomez
@selenagomez
60.5M followers